Aclaris Therapeutics Files Form 4 on 2026-04-27
Ticker: ACRS · Form: 4 · Filed: Apr 27, 2026 · CIK: 0001557746
| Field | Detail |
|---|---|
| Company | Aclaris Therapeutics, Inc. (ACRS) |
| Form Type | 4 |
| Filed Date | Apr 27, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: insider-filing, ownership-change
Related Tickers: ACRS
TL;DR
Aclaris Therapeutics (ACRS) insiders filed a Form 4 on 4/27/26. Ownership changes incoming.
AI Summary
On April 27, 2026, Aclaris Therapeutics, Inc. filed a Form 4, indicating a change in beneficial ownership of securities. The filing details transactions by individuals associated with the company, including Leonard Braden Michael, who is listed with a mailing and business address in Wayne, PA.
Why It Matters
Form 4 filings are crucial for investors as they disclose changes in stock ownership by company insiders, which can signal their confidence or concerns about the company's future.
Risk Assessment
Risk Level: low — This filing is a standard disclosure of insider stock transactions and does not inherently indicate increased risk for the company.
Key Numbers
- 2026-04-27 — Filing Date (Date of the Form 4 filing)
Key Players & Entities
- Aclaris Therapeutics, Inc. (company) — Issuer
- Leonard Braden Michael (person) — Reporting Person
- 0001557746 (company) — Issuer CIK
- 0001373603 (person) — Reporting Person CIK
FAQ
What type of form was filed by Aclaris Therapeutics, Inc.?
Aclaris Therapeutics, Inc. filed a Form 4, which is a Statement of changes in beneficial ownership of securities.
When was the Form 4 filing accepted by the SEC?
The Form 4 filing was accepted on 2026-04-27 at 19:27:01.
Who is listed as a reporting person in this filing?
Leonard Braden Michael is listed as a reporting person.
What is the business address of Aclaris Therapeutics, Inc.?
The business address of Aclaris Therapeutics, Inc. is 701 LEE ROAD SUITE 103 WAYNE PA 19087.
What is the CIK number for Aclaris Therapeutics, Inc.?
The CIK number for Aclaris Therapeutics, Inc. is 0001557746.
Filing Details
This Statement of Changes in Beneficial Ownership (Form 4) was filed with the SEC on April 27, 2026 by Leonard Braden Michael regarding Aclaris Therapeutics, Inc. (ACRS). Form 4 filings disclose purchases, sales, or other changes in ownership by company insiders such as officers, directors, and major shareholders.